NCT00668902
Rapid Screening Phenotype Test To Evaluate CYP 2C19 Enzyme Activity Using Stable Isotope [13C]Pantoprazole
See it on ClinicalTrials.gov ↗25 people
60%
40%
15 womenmiddle line = equal numbers10 men
- Phase
- NA
- Paid for by
- Indiana University
- Finished
- 2009-01
- Health conditions
- Healthy
- Who could join
- Anyone
- Ages
- 18 Years – 49 Years
- Average age
- mean 25.63 years
- Age 65+
- Not reported
- Weight (BMI)
- mean 24.2 kg/m^2
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- Age limit under 65
Older women were turned away, even though they often take this medicine.
“Maximum age: 49 Years.”
- No pregnant women
Women who were pregnant could not join.
“Female subjects who are pregnant or lactating.”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Female subjects who are pregnant or lactating.”
- No hormonal birth control
Women on the pill, patch, ring, shot, implant or hormonal IUD could not join.
“Female subjects currently taking oral contraceptive birth control pills and who are unwilling or unable to stop oral contraceptives and use a barrier contraceptive method (such as condom, contraceptive foams, etc.) starting from the time of…”
- Weight limit (BMI)
Women with a higher (or lower) body weight were turned away.
“Subjects with BMI \<30 which will be determined by Metropolitan height and weight tables. Subjects must weigh at least 110 pounds.”
Study titles and rules are shown in their original English.